Literature DB >> 26108691

Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.

K Durinck1, W Van Loocke1, J Van der Meulen1, I Van de Walle2, M Ongenaert1, P Rondou1, A Wallaert1, C E de Bock3, N Van Roy1, B Poppe1, J Cools3, J Soulier4, T Taghon2, F Speleman1, P Van Vlierberghe1.   

Abstract

The TLX1 transcription factor is critically involved in the multi-step pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) and often cooperates with NOTCH1 activation during malignant T-cell transformation. However, the exact molecular mechanism by which these T-cell specific oncogenes cooperate during transformation remains to be established. Here, we used chromatin immunoprecipitation followed by sequencing to establish the genome-wide binding pattern of TLX1 in human T-ALL. This integrative genomics approach showed that ectopic TLX1 expression drives repression of T cell-specific enhancers and mediates an unexpected transcriptional antagonism with NOTCH1 at critical target genes, including IL7R and NOTCH3. These phenomena coordinately trigger a TLX1-driven pre-leukemic phenotype in human thymic precursor cells, reminiscent of the thymus regression observed in murine TLX1 tumor models, and create a strong genetic pressure for acquiring activating NOTCH1 mutations as a prerequisite for full leukemic transformation. In conclusion, our results uncover a functional antagonism between cooperative oncogenes during the earliest phases of tumor development and provide novel insights in the multi-step pathogenesis of TLX1-driven human leukemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26108691     DOI: 10.1038/leu.2015.162

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  30 in total

1.  Using MACS to identify peaks from ChIP-Seq data.

Authors:  Jianxing Feng; Tao Liu; Yong Zhang
Journal:  Curr Protoc Bioinformatics       Date:  2011-06

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

4.  The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.

Authors:  Kaat Durinck; Annelynn Wallaert; Inge Van de Walle; Wouter Van Loocke; Pieter-Jan Volders; Suzanne Vanhauwaert; Ellen Geerdens; Yves Benoit; Nadine Van Roy; Bruce Poppe; Jean Soulier; Jan Cools; Pieter Mestdagh; Jo Vandesompele; Pieter Rondou; Pieter Van Vlierberghe; Tom Taghon; Frank Speleman
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

5.  Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions.

Authors:  Inge Van de Walle; Greet De Smet; Martina Gärtner; Magda De Smedt; Els Waegemans; Bart Vandekerckhove; Georges Leclercq; Jean Plum; Jon C Aster; Irwin D Bernstein; Cynthia J Guidos; Bruno Kyewski; Tom Taghon
Journal:  Blood       Date:  2011-03-03       Impact factor: 22.113

6.  Transforming function of the HOX11/TCL3 homeobox gene.

Authors:  R G Hawley; A Z Fong; M D Reis; N Zhang; M Lu; T S Hawley
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

7.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

8.  The TLX1 oncogene drives aneuploidy in T cell transformation.

Authors:  Kim De Keersmaecker; Pedro J Real; Giusy Della Gatta; Teresa Palomero; Maria Luisa Sulis; Valeria Tosello; Pieter Van Vlierberghe; Kelly Barnes; Mireia Castillo; Xavier Sole; Michael Hadler; Jack Lenz; Peter D Aplan; Michelle Kelliher; Barbara L Kee; Pier Paolo Pandolfi; Dietmar Kappes; Fotini Gounari; Howard Petrie; Joni Van der Meulen; Frank Speleman; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Jean Soulier; David Avran; Hélène Cavé; Nicole Dastugue; Susana Raimondi; Jules P P Meijerink; Carlos Cordon-Cardo; Andrea Califano; Adolfo A Ferrando
Journal:  Nat Med       Date:  2010-10-24       Impact factor: 53.440

9.  MEME-ChIP: motif analysis of large DNA datasets.

Authors:  Philip Machanick; Timothy L Bailey
Journal:  Bioinformatics       Date:  2011-04-12       Impact factor: 6.937

10.  A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.

Authors:  Daniel Herranz; Alberto Ambesi-Impiombato; Teresa Palomero; Stephanie A Schnell; Laura Belver; Agnieszka A Wendorff; Luyao Xu; Mireia Castillo-Martin; David Llobet-Navás; Carlos Cordon-Cardo; Emmanuelle Clappier; Jean Soulier; Adolfo A Ferrando
Journal:  Nat Med       Date:  2014-09-07       Impact factor: 53.440

View more
  15 in total

1.  T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.

Authors:  Charles E de Bock; Michelle Down; Kinsha Baidya; Bram Sweron; Andrew W Boyd; Mark Fiers; Gordon F Burns; Timothy J Molloy; Richard B Lock; Jean Soulier; Tom Taghon; Pieter Van Vlierberghe; Jan Cools; Jeff Holst; Rick F Thorne
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

2.  A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.

Authors:  Karen Verboom; Wouter Van Loocke; Pieter-Jan Volders; Bieke Decaesteker; Francisco Avila Cobos; Simon Bornschein; Charles E de Bock; Zeynep Kalender Atak; Emmanuelle Clappier; Stein Aerts; Jan Cools; Jean Soulier; Tom Taghon; Pieter Van Vlierberghe; Jo Vandesompele; Frank Speleman; Kaat Durinck
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

3.  Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.

Authors:  S Peirs; V Frismantas; F Matthijssens; W Van Loocke; T Pieters; N Vandamme; B Lintermans; M P Dobay; G Berx; B Poppe; S Goossens; B C Bornhauser; J-P Bourquin; P Van Vlierberghe
Journal:  Leukemia       Date:  2017-01-11       Impact factor: 11.528

4.  Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia.

Authors:  A Wallaert; K Durinck; W Van Loocke; I Van de Walle; F Matthijssens; P J Volders; F Avila Cobos; D Rombaut; P Rondou; P Mestdagh; J Vandesompele; B Poppe; T Taghon; J Soulier; P Van Vlierberghe; F Speleman
Journal:  Leukemia       Date:  2016-04-22       Impact factor: 11.528

5.  Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.

Authors:  Laurent Renou; Pierre-Yves Boelle; Caroline Deswarte; Salvatore Spicuglia; Aissa Benyoucef; Julien Calvo; Benjamin Uzan; Mohamed Belhocine; Agata Cieslak; Judith Landman-Parker; Andre Baruchel; Vahid Asnafi; Françoise Pflumio; Paola Ballerini; Irina Naguibneva
Journal:  Blood Adv       Date:  2017-05-04

6.  The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.

Authors:  V L Ha; A Luong; F Li; D Casero; J Malvar; Y M Kim; R Bhatia; G M Crooks; C Parekh
Journal:  Leukemia       Date:  2017-02-24       Impact factor: 11.528

7.  The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.

Authors:  Yinfei Tan; Eleonora Sementino; Jinfei Xu; Jianming Pei; Zemin Liu; Timothy K Ito; Kathy Q Cai; Suraj Peri; Andres J P Klein-Szanto; David L Wiest; Joseph R Testa
Journal:  Oncotarget       Date:  2017-02-28

Review 8.  The role of long non-coding RNA BCAR4 in human cancers.

Authors:  Qiong Yi; Zhongcheng Liu; Kun Zhang; Xuening Liu; Lifu Wang; Bin Geng; Yayi Xia
Journal:  Hum Cell       Date:  2021-05-27       Impact factor: 4.174

9.  A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.

Authors:  Javier Robles-Valero; L Francisco Lorenzo-Martín; Mauricio Menacho-Márquez; Isabel Fernández-Pisonero; Antonio Abad; Mireia Camós; María L Toribio; Lluis Espinosa; Anna Bigas; Xosé R Bustelo
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

10.  Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.

Authors:  Farzaneh Ghazavi; Barbara De Moerloose; Wouter Van Loocke; Annelynn Wallaert; Hetty H Helsmoortel; Alina Ferster; Marleen Bakkus; Geneviève Plat; Eric Delabesse; Anne Uyttebroeck; Filip Van Nieuwerburgh; Dieter Deforce; Nadine Van Roy; Frank Speleman; Yves Benoit; Tim Lammens; Pieter Van Vlierberghe
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.